Related Experiment Video
Updated: Apr 6, 2026

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Published on: May 17, 2014
Assessment of mTOR-Dependent Translational Regulation of Interferon Stimulated Genes
Mark Livingstone1, Kristina Sikström2, Philippe A Robert1
1Cytokine Signaling Unit, Institut Pasteur, CNRS URA1961, Paris, France.
Abstract:
Type-I interferon (IFN)-induced activation of the mammalian target of rapamycin (mTOR) signaling pathway has been implicated in translational control of mRNAs encoding interferon-stimulated genes (ISGs). However, mTOR-sensitive translatomes commonly include mRNAs with a 5' terminal oligopyrimidine tract (TOP), such as those encoding ribosomal proteins, but not ISGs. Because these translatomes were obtained under conditions when ISG expression is not induced, we examined the mTOR-sensitive translatome in human WISH cells stimulated with IFN β. The mTOR inhibitor Torin1 resulted in a repression of global protein synthesis, including that of ISG products, and translation of all but 3 ISG mRNAs (TLR3, NT5C3A, and RNF19B) was not selectively more sensitive to mTOR inhibition. Detailed studies of NT5C3A revealed an IFN-induced change in transcription start site resulting in a switch from a non-TOP to a TOP-like transcript variant and mTOR sensitive translation. Thus, we show that, in the cell model used, translation of the vast majority of ISG mRNAs is not selectively sensitive to mTOR activity and describe an uncharacterized mechanism wherein the 5'-UTR of an mRNA is altered in response to a cytokine, resulting in a shift from mTOR-insensitive to mTOR-sensitive translation.
Insights
Type-I interferon (IFN) does not selectively control most interferon-stimulated gene (ISG) mRNA translation via the mTOR pathway. However, one ISG mRNA shifts to mTOR-sensitive translation by altering its 5' untranslated region.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Type-I interferon (IFN) signaling activates the mammalian target of rapamycin (mTOR) pathway, impacting protein synthesis.
- mTOR-sensitive translatomes typically contain 5' terminal oligopyrimidine tract (TOP) mRNAs, like those for ribosomal proteins, but not interferon-stimulated genes (ISGs).
Purpose of the Study:
- To investigate the mTOR-sensitive translatome of ISG mRNAs under IFN-β stimulation.
- To elucidate the translational control mechanisms of ISG mRNAs in response to Type-I IFN.
Main Methods:
- Human WISH cells were stimulated with IFN-β.
- The mTOR inhibitor Torin1 was used to assess global protein synthesis and specific ISG mRNA translation.
- Detailed analysis of NT5C3A mRNA identified changes in its 5' untranslated region (5'-UTR).
Main Results:
- IFN-β stimulation did not result in selective mTOR-sensitive translation for most ISG mRNAs.
- Torin1 treatment repressed global protein synthesis, including ISG products.
- NT5C3A mRNA exhibited an IFN-induced shift from a non-TOP to a TOP-like variant, rendering its translation mTOR-sensitive.
Conclusions:
- The translation of most ISG mRNAs is not selectively sensitive to mTOR activity during Type-I IFN response.
- An uncharacterized mechanism involves cytokine-induced alteration of an mRNA's 5'-UTR, switching its translation from mTOR-insensitive to mTOR-sensitive.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Inhibitors of Viral Protein Synthesis
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

